1. Home
  2. UTSI vs TENX Comparison

UTSI vs TENX Comparison

Compare UTSI & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UTSI
  • TENX
  • Stock Information
  • Founded
  • UTSI 1991
  • TENX 1967
  • Country
  • UTSI China
  • TENX United States
  • Employees
  • UTSI N/A
  • TENX N/A
  • Industry
  • UTSI Telecommunications Equipment
  • TENX Biotechnology: Pharmaceutical Preparations
  • Sector
  • UTSI Telecommunications
  • TENX Health Care
  • Exchange
  • UTSI Nasdaq
  • TENX Nasdaq
  • Market Cap
  • UTSI 25.9M
  • TENX 21.7M
  • IPO Year
  • UTSI 2000
  • TENX N/A
  • Fundamental
  • Price
  • UTSI $2.50
  • TENX $6.37
  • Analyst Decision
  • UTSI
  • TENX Strong Buy
  • Analyst Count
  • UTSI 0
  • TENX 3
  • Target Price
  • UTSI N/A
  • TENX $16.00
  • AVG Volume (30 Days)
  • UTSI 2.4K
  • TENX 43.8K
  • Earning Date
  • UTSI 04-11-2025
  • TENX 03-25-2025
  • Dividend Yield
  • UTSI N/A
  • TENX N/A
  • EPS Growth
  • UTSI N/A
  • TENX N/A
  • EPS
  • UTSI N/A
  • TENX N/A
  • Revenue
  • UTSI $10,878,000.00
  • TENX N/A
  • Revenue This Year
  • UTSI N/A
  • TENX N/A
  • Revenue Next Year
  • UTSI N/A
  • TENX N/A
  • P/E Ratio
  • UTSI N/A
  • TENX N/A
  • Revenue Growth
  • UTSI N/A
  • TENX N/A
  • 52 Week Low
  • UTSI $2.20
  • TENX $2.77
  • 52 Week High
  • UTSI $3.22
  • TENX $7.89
  • Technical
  • Relative Strength Index (RSI)
  • UTSI 54.61
  • TENX 53.10
  • Support Level
  • UTSI $2.39
  • TENX $6.00
  • Resistance Level
  • UTSI $2.41
  • TENX $6.76
  • Average True Range (ATR)
  • UTSI 0.04
  • TENX 0.39
  • MACD
  • UTSI 0.02
  • TENX 0.03
  • Stochastic Oscillator
  • UTSI 100.00
  • TENX 63.16

About UTSI UTStarcom Holdings Corp.

UTStarcom Holdings Corp operates as a telecom infrastructure provider. It develops technology for bandwidth from cloud-based services, mobile, streaming, and other applications. The range of solutions is designed to expand and modernize telecommunications networks through smooth network system integration, lower operating costs, and increased broadband access. The business activity of the firm is operated through the Equipment and Service segment. The Equipment segment is focused on equipment sales, including network infrastructure and application products, and the Service segment is engaged in providing services and support of equipment products and also the new operational support. The company operates in China, India, Japan, Taiwan and other countries.

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

Share on Social Networks: